title: Metronomic chemotherapy in elderly patients: do risks exceed benefits in some patients?
authors.forename: Ermenegildo
authors.initials: E
authors.lastname: Arnoldi
authors.forename: Maria
authors.initials: M
authors.lastname: Dieli
authors.forename: Marina
authors.initials: M
authors.lastname: Mangia
authors.forename: Roberto
authors.initials: R
authors.lastname: Labianca
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced; D000369:Aged, 80 and over; D000740:Anemia / Q000139:chemically induced; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000556:secondary; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D016330:Frail Elderly; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D007415:Intestinal Obstruction / Q000139:chemically induced; D007970:Leukopenia / Q000139:chemically induced; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008207:Lymphatic Metastasis; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D009503:Neutropenia / Q000139:chemically induced
chemical_list: D003520:Cyclophosphamide; D008727:Methotrexate